Viking Therapeutics (GB:0VQA)
LSE:0VQA
Holding GB:0VQA?
Track your performance easily

Viking Therapeutics (0VQA) Financial Statements

9 Followers

Viking Therapeutics Financial Overview

Viking Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Viking Therapeutics is scheduled to report earnings on October 30, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -22.25M$ -27.36M$ 4.48M$ -22.53M$ -19.23M
EBITDA$ -19.34M$ -30.07M$ 33.57M-$ -19.12M
Net Income Common Stockholders$ -22.23M$ -27.36M$ -24.61M$ -22.53M$ -19.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 942.26M$ 962.98M$ 362.08M$ 376.24M$ 392.92M
Total Assets$ 946.84M$ 967.52M$ 368.49M$ 382.66M$ 400.69M
Total Debt$ 1.10M$ 1.18M$ 1.26M$ 1.34M$ 1.41M
Net Debt$ -941.16M$ -961.79M$ -360.82M$ -374.90M$ -391.51M
Total Liabilities$ 25.86M$ 33.63M$ 20.07M$ 14.42M$ 14.58M
Stockholders Equity$ 920.98M$ 933.89M$ 348.42M$ 368.24M$ 386.12M
Cash Flow-
Free Cash Flow$ -28.51M$ -6.13M$ -17.64M-$ -11.44M
Operating Cash Flow$ -28.51M$ -6.13M$ -17.64M$ -19.66M$ -11.44M
Investing Cash Flow$ -126.06M$ -459.79M$ 35.73M$ -12.53M$ -204.48M
Financing Cash Flow$ 2.90M$ 606.04M$ 188.00K$ -74.00K$ 267.08M
Currency in USD

Viking Therapeutics Earnings and Revenue History

Viking Therapeutics Debt to Assets

Viking Therapeutics Cash Flow

Viking Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis